ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

Market Cap	31.07B
Revenue (ttm)	62.69B
Net Income (ttm)	-9.60B
Shares Out	30.98M
EPS (ttm)	-310.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,697
Average Volume	132,639
Open	1,007.00
Previous Close	1,009.00
Day's Range	1,003.00 - 1,011.00
52-Week Range	797.00 - 1,897.00
Beta	0.60
RSI	38.22
Earnings Date	Mar 14, 2025

About KOSDAQ:034940

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i...

• Industry: Pharmaceutical Preparations
• Founded: 1964
• Employees: 250
• Stock Exchange: KOSDAQ
• Ticker Symbol: 034940

Financial Performance

In 2024, KOSDAQ:034940's revenue was 62.69 billion, a decrease of -0.44% compared to the previous year's 62.97 billion. Losses were -9.60 billion, -8.65% less than in 2023.